ESMO 2017: Abdominal Fat a Key Cancer Driver for Postmenopausal Women
Body fat distribution in the trunk is more important than body weight when it comes…
Browsing: ESMO 2017
ESMO 2017: Adjuvant Nivolumab Superior to Ipilimumab in Surgically Resected Stage III/IV Melanoma
Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage…
ESMO 2017: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma
Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage…
ESMO 2017: LORELEI: Taselisib Boosts Breast Tumour Shrinkage
Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer…
ESMO 2017: Study in Early Stage Breast Cancer Shows That Even Small Tumours Can Be Aggressive
Even small tumours can be aggressive, according to a study in patients with early stage…
ESMO 2017: Some stroke survivors may have underlying cancer
Some stroke survivors may have underlying cancer, according to an observational study to be presented…
ESMO 2017: Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer
The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid,…
ESMO 2017: DNA Sequencing Could Open Up New Drug Indications for Patients with Rare Cancers
Thanks to DNA sequencing, patients with rare cancers for which no standard treatment is available…
ESMO 2017: Patients feel psycho-social impact of chemo more acutely than physical side effects
The preliminary results of a study presented at the ESMO 2017 Congress in Madrid show…
ESMO 2017: New Data Confirms Superiority of Docetaxel Based Triplet Therapy in Gastric Cancer
The superiority of docetaxel based triplet therapy over standard care in patients with resectable oesophago-gastric…